Policy Updates

A new study that quantifies industry financial conflicts of interest (FCOIs) found that nearly nine out of 10 physicians and researchers who helped develop the National Comprehensive Network (NCCN) guidelines reported financial ties to the pharmaceutical and medical device industries. 
European Society of Cardiology has published a novel position paper tackling the problem of cardiac toxicity associated with anticancer therapies.
A team of researchers is recommending an overhaul of the process that determines which cancer drugs used off-label are reimbursed by federally-funded health insurance in the United States.